NEWS FLASH: Alabama's @AerBetic collects Innovation Award at #CES2020, making a splash at the world's top consumer tech show for a second straight year https://t.co/vDEuiFDBJ5
Day 2 at @ces 2020 is underway. Excited to share the @aerbetic story. Come see us, Sands Tech West Booth 42137. @ Sands Expo Convention Center https://t.co/CH4wCYXIfJ
Alabama's presence at #CES2020 -- the world's top tech show -- includes homegrown inventions and a recruiting push to advance state in the sector https://t.co/4AajpoBDVZ
Proud and honored to be recognized with a 2020 CES Innovation Award in Health and Wellness! #diabetes#wearable@ces@aernos @pushproductdesign https://t.co/eDI5TifeMI
The drug, Rybelsus, with the active ingredient semaglutide, is the first pill in a class of drugs called glucagon-like peptide, GLP-1, approved for use in the United States. https://t.co/W4LPCKTXzj
"What if insulin isn’t necessary for life? What if the symptoms of T1DM are not caused by the lack of insulin? What if the insulinocentric dogma of diabetes is false?" https://t.co/3I5xhuJ7CQ
@google, @amazon, @Apple and other big tech companies are all honing in on diabetes technology as an area of focus. To succeed, these companies are partnering with traditional medical device makers. https://t.co/Vrpbm5PVG5